StockData
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Biotherapeutics Inc. (LABT) income statement

LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.24+0.03 (+15.03%)

Close on Nov 20, 2026Market cap $580.34KP/E –Yield –

Lakewood-Amedex Biotherapeutics Inc. financial ratios

See a number that looks wrong?